IS4947A - Tróvafloxasín mesýlat tafla - Google Patents

Tróvafloxasín mesýlat tafla

Info

Publication number
IS4947A
IS4947A IS4947A IS4947A IS4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A
Authority
IS
Iceland
Prior art keywords
troafloxacin
mesylate tablet
mesylate
tablet
troafloxacin mesylate
Prior art date
Application number
IS4947A
Other languages
English (en)
Inventor
Dale Johnson Alton
Michael Sinko Christopher
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS4947A publication Critical patent/IS4947A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4947A 1998-01-21 1999-01-19 Tróvafloxasín mesýlat tafla IS4947A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
IS4947A true IS4947A (is) 1999-07-22

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4947A IS4947A (is) 1998-01-21 1999-01-19 Tróvafloxasín mesýlat tafla

Country Status (34)

Country Link
US (1) US6187341B1 (is)
EP (1) EP0930068A3 (is)
JP (1) JPH11269072A (is)
KR (1) KR100314977B1 (is)
CN (1) CN1227743A (is)
AP (1) AP1094A (is)
AR (1) AR012780A1 (is)
AU (1) AU758381B2 (is)
BG (1) BG103106A (is)
BR (1) BR9900116A (is)
CA (1) CA2259698C (is)
CO (1) CO4810225A1 (is)
DZ (1) DZ2712A1 (is)
EA (1) EA003247B1 (is)
GT (1) GT199900004A (is)
HR (1) HRP990023A2 (is)
HU (1) HUP9900154A3 (is)
ID (1) ID23735A (is)
IL (1) IL128051A0 (is)
IS (1) IS4947A (is)
MA (1) MA24747A1 (is)
NO (1) NO990243L (is)
NZ (1) NZ333838A (is)
OA (1) OA10958A (is)
PA (1) PA8466701A1 (is)
PE (1) PE20000169A1 (is)
PL (1) PL330981A1 (is)
SG (1) SG70666A1 (is)
SK (1) SK4299A3 (is)
TN (1) TNSN99007A1 (is)
TR (1) TR199900089A2 (is)
TW (1) TW518224B (is)
YU (1) YU2399A (is)
ZA (1) ZA99393B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100650489B1 (ko) * 1998-11-10 2006-11-28 바이엘 헬스케어 아게 목시플록사신 제약 제제
AU1188601A (en) * 1999-09-20 2001-04-24 Alza Corporation Process for lessening polymorphic conversion of a drug
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
ES2320984T3 (es) * 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
DE60318384T2 (de) * 2003-03-19 2009-02-19 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäuren enthalten
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
ES2515101T3 (es) 2004-06-04 2014-10-29 Debiopharm International Sa Derivados de acrilamida como agentes antibióticos
JP5046946B2 (ja) * 2004-10-15 2012-10-10 スパーナス ファーマシューティカルズ インコーポレイテッド 低乱用性薬学的製剤
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
NZ312199A (en) * 1995-08-29 1999-06-29 Pfizer Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
AP9901443A0 (en) 1999-03-31
KR100314977B1 (ko) 2001-11-24
SG70666A1 (en) 2000-02-22
HU9900154D0 (en) 1999-03-29
CN1227743A (zh) 1999-09-08
NZ333838A (en) 2000-03-27
DZ2712A1 (fr) 2003-09-01
OA10958A (en) 2001-10-31
EA199900046A2 (ru) 1999-08-26
AR012780A1 (es) 2000-11-08
HUP9900154A3 (en) 2000-12-28
TW518224B (en) 2003-01-21
EP0930068A2 (en) 1999-07-21
BG103106A (en) 1999-08-31
BR9900116A (pt) 2000-05-02
CA2259698C (en) 2003-04-15
AP1094A (en) 2002-08-19
ID23735A (id) 2000-05-11
TR199900089A3 (tr) 1999-10-21
HRP990023A2 (en) 1999-08-31
NO990243L (no) 1999-07-22
AU1217399A (en) 1999-08-12
HUP9900154A2 (hu) 1999-09-28
NO990243D0 (no) 1999-01-20
TNSN99007A1 (fr) 2005-11-10
PE20000169A1 (es) 2000-03-10
PA8466701A1 (es) 2000-09-29
GT199900004A (es) 2000-07-08
US6187341B1 (en) 2001-02-13
IL128051A0 (en) 1999-11-30
SK4299A3 (en) 2000-06-12
AU758381B2 (en) 2003-03-20
CO4810225A1 (es) 1999-06-30
EP0930068A3 (en) 1999-12-22
MA24747A1 (fr) 1999-10-01
PL330981A1 (en) 1999-08-02
EA199900046A3 (ru) 1999-12-29
JPH11269072A (ja) 1999-10-05
EA003247B1 (ru) 2003-02-27
CA2259698A1 (en) 1999-07-21
TR199900089A2 (xx) 1999-10-21
ZA99393B (en) 2000-07-21
YU2399A (sh) 2002-06-19
KR19990068014A (ko) 1999-08-25

Similar Documents

Publication Publication Date Title
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
DE69937850D1 (de) Hautablationslaser
ATE341990T1 (de) Sigmidoskop
IS5869A (is) Hraðlosandi tafla
ID23234A (id) Turunan-turunan benzosulfona
ID29089A (id) Sediaan farmasi moksifloksasin
ID27484A (id) Turunan adenosina
NO990113D0 (no) Flerskrog-fart°y
IS4947A (is) Tróvafloxasín mesýlat tafla
ID27547A (id) Turunan kuinolin
ATE262513T1 (de) Benzoylpyridazine
DE60044181D1 (de) Gleitvorrichtung
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
ID28356A (id) Turunam tiazola
DE59808995D1 (de) Endomikroskopsystem
NO980087L (no) Klammer
DE29801440U1 (de) Tabletten-Einnahmehilfe
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59901263D1 (de) Einzelplatz-sortierer
DE29813269U1 (de) Tablette
ATA126298A (de) Verpuffungsklappe
DE29819079U1 (de) Kombuchalyophilisat
UA2845S (uk) Таблетка